Medincell (XPAR:MEDCL) Total Assets : €50.49 Mil (As of Sep. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Medincell Total Assets?

Medincell's Total Assets for the quarter that ended in Sep. 2023 was €50.49 Mil.

During the past 12 months, Medincell's average Total Assets Growth Rate was 27.60% per year. During the past 3 years, the average Total Assets Growth Rate was 15.30% per year. During the past 5 years, the average Total Assets Growth Rate was 5.10% per year.

During the past 8 years, Medincell's highest 3-Year average Total Assets Growth Rate was 24.30%. The lowest was -6.00%. And the median was 8.70%.

Total Assets is connected with ROA %. Medincell's annualized ROA % for the quarter that ended in Sep. 2023 was -40.88%. Total Assets is also linked to Revenue through Asset Turnover. Medincell's Asset Turnover for the quarter that ended in Sep. 2023 was 0.18.

Medincell Total Assets Historical Data

The historical data trend for Medincell's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medincell Total Assets Chart

Medincell Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Total Assets

Get a 7-Day Free Trial

37.98

27.31

63.61

44.30

29.34

Medincell Semi-Annual Data
	Mar16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Total Assets	Get a 7-Day Free Trial										54.80	44.30	32.78	29.34	50.49

Medincell Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Medincell's Total Assets for the fiscal year that ended in Mar. 2023 is calculated as

Total Assets	=	Total Equity (A: Mar. 2023 )	+	Total Liabilities (A: Mar. 2023 )
	=	-42.294	+	71.633
	=	29.34

Medincell's Total Assets for the quarter that ended in Sep. 2023 is calculated as

Total Assets	=	Total Equity (Q: Sep. 2023 )	+	Total Liabilities (Q: Sep. 2023 )
	=	-25.747	+	76.236
	=	50.49

Medincell (XPAR:MEDCL) Total Assets Explanation

Total Assets is connected with ROA %.

Medincell's annualized ROA % for the quarter that ended in Sep. 2023 is

ROA %	=	Net Income (Q: Sep. 2023 )	/	( (Total Assets (Q: Mar. 2023 )	+	Total Assets (Q: Sep. 2023 ))	/ count )
	=	-16.316	/	( (29.339	+	50.489)	/ 2 )
	=	-16.316	/	39.914
	=	-40.88 %

Note: The Net Income data used here is two times the semi-annual (Sep. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Medincell's Asset Turnover for the quarter that ended in Sep. 2023 is

	Asset Turnover
=	Revenue (Q: Sep. 2023 )	/	( (Total Assets (Q: Mar. 2023 )	+	Total Assets (Q: Sep. 2023 ))	/ count )
=	6.985	/	( (29.339	+	50.489)	/ 2 )
=	6.985	/	39.914
=	0.18

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Medincell Total Assets Related Terms

Thank you for viewing the detailed overview of Medincell's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Medincell (XPAR:MEDCL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medincell SA (XPAR:MEDCL) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

MEB:Germany

Address

3 rue des Freres Lumiere, Jacou, FRA, 34830

Website

https://www.medincell.com

Medincell SA is a technology-based pharmaceutical firm, aims to optimise the efficiency of medical treatments and make them accessible geographically. The company's product portfolio uses BEPO-patented technology to develop controlled, long-acting injectable medical treatments for a number of therapeutic fields. The firm has a single operating segment: ongoing research and development on processes that use biodegradable polymers to enable the controlled and prolonged release of the active principles of drugs into the human body and animals by means of injection.

Medincell (XPAR:MEDCL) Headlines

No Headlines